Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 506 entries
View as:

Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01252667 Org: User:
Start: 01/25/11 End: 03/31/19 Due: 03/31/20

Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00002790 Org: User:
Start: 03/31/96 End: - Due: -

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

Phase: N/A Priority: Normal
NCT ID: NCT06771739 Org: User:
Start: 06/21/25 End: 07/31/25 Due: 07/31/26

Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00126477 Org: User:
Start: 03/31/96 End: 03/31/10 Due: 03/31/11

Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00052598 Org: User:
Start: 09/30/02 End: 06/30/11 Due: 06/30/12

Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study

Phase: N/A Priority: Normal
NCT ID: NCT04447313 Org: User:
Start: 03/05/21 End: 11/09/26 Due: 11/09/27

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations

Phase: N/A Priority: Normal
NCT ID: NCT06043713 Org: User:
Start: 12/15/23 End: 02/09/26 Due: 02/09/27

Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS

Phase: N/A Priority: Normal
NCT ID: NCT02921061 Org: User:
Start: 11/17/16 End: 10/24/18 Due: 10/24/19

Acute Exercise Intervention in Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT03779867 Org: User:
Start: 03/25/19 End: 12/31/24 Due: 12/31/25

Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02770820 Org: User:
Start: 11/06/17 End: 06/01/20 Due: 06/01/21

Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00968630 Org: User:
Start: 12/17/09 End: 03/17/17 Due: 03/17/18

H-PACE Program for the Improvement of Lifestyle Behaviors Among Children

Phase: N/A Priority: Normal
NCT ID: NCT06548074 Org: User:
Start: 01/22/24 End: 06/30/25 Due: 06/30/26

TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02180698 Org: User:
Start: 11/17/14 End: 10/07/16 Due: 10/07/17

Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm

Phase: N/A Priority: Normal
NCT ID: NCT06545344 Org: User:
Start: 09/01/25 End: 01/01/26 Due: 01/01/27

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

Phase: N/A Priority: Normal
NCT ID: NCT03980769 Org: User:
Start: 05/05/21 End: 07/01/27 Due: 07/01/28

Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

Phase: N/A Priority: Normal
NCT ID: NCT04965597 Org: User:
Start: 04/19/22 End: 12/31/26 Due: 12/31/27

Tositumomab and Iodine I 131 Tositumomab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission

Phase: N/A Priority: Normal
NCT ID: NCT00476047 Org: User:
Start: 02/28/07 End: 02/28/15 Due: 02/28/16

Trial of An Innovative Smartphone Intervention for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT02724462 Org: User:
Start: 05/27/17 End: 12/27/19 Due: 12/27/20

Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00073931 Org: User:
Start: 10/31/99 End: 07/31/14 Due: 07/31/15

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Phase: N/A Priority: Normal
NCT ID: NCT00118326 Org: User:
Start: 08/31/03 End: 05/31/07 Due: 05/31/08

Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission

Phase: N/A Priority: Normal
NCT ID: NCT01465386 Org: User:
Start: 11/30/11 End: 03/02/15 Due: 03/02/16

Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00008450 Org: User:
Start: 08/11/97 End: 12/26/18 Due: 12/26/19

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003972 Org: User:
Start: 07/31/98 End: 03/31/03 Due: 03/31/04

Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT03338959 Org: User:
Start: 03/28/18 End: 08/04/23 Due: 08/04/24

Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00024037 Org: User:
Start: 04/30/95 End: 12/31/02 Due: 12/31/03